Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Non-Current Debt (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Non-Current Debt for 11 consecutive years, with $13.4 million as the latest value for Q3 2025.

  • Quarterly Non-Current Debt fell 11.34% to $13.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13.4 million through Sep 2025, down 11.34% year-over-year, with the annual reading at $15.2 million for FY2024, 0.98% up from the prior year.
  • Non-Current Debt hit $13.4 million in Q3 2025 for STRATA Skin Sciences, down from $15.3 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $15.3 million in Q2 2025 to a low of $497000.0 in Q2 2021.
  • Historically, Non-Current Debt has averaged $10.7 million across 5 years, with a median of $13.4 million in 2025.
  • Biggest five-year swings in Non-Current Debt: crashed 71.26% in 2021 and later surged 1387.93% in 2022.
  • Year by year, Non-Current Debt stood at $7.3 million in 2021, then rose by 2.15% to $7.5 million in 2022, then soared by 101.23% to $15.0 million in 2023, then grew by 0.98% to $15.2 million in 2024, then fell by 11.57% to $13.4 million in 2025.
  • Business Quant data shows Non-Current Debt for SSKN at $13.4 million in Q3 2025, $15.3 million in Q2 2025, and $15.2 million in Q1 2025.